[Featured Stock] SK Biopharm Turns Up After 6 Days

[Asia Economy Reporter Song Hwajeong] SK Biopharm has turned to an upward trend after 6 days.

As of 9:10 AM on the 16th, SK Biopharm was trading at 189,000 KRW, up 6.78% (12,000 KRW) from the previous day. SK Biopharm, which made a spectacular debut on the KOSPI market on the 2nd, recorded the upper price limit for three consecutive days after listing but then showed a weak trend as profit-taking selling flooded the market.

With a significant rise for the first time in a while, its market capitalization ranking also climbed back up to 18th place. Based on the previous day's closing price, it had fallen to 21st place.

Recently, the weakness of SK Biopharm was led by foreigners. Foreigners continuously showed selling pressure right after SK Biopharm's listing, realizing profits. From the 2nd to the previous day, foreigners sold SK Biopharm shares worth 786 billion KRW, making them the largest sellers. On the other hand, during this period, individuals and institutions continuously bought SK Biopharm. Institutions purchased SK Biopharm every day since listing, with a net buying amount of 179.9 billion KRW. Individuals also net bought 616.4 billion KRW, making both institutions and individuals the largest buyers of SK Biopharm this month.

It is expected that once the foreign selling pressure subsides to some extent, the stock will continue its strong trend. Early inclusion in the KOSPI200 index is also considered likely. According to the special inclusion clause for newly listed stocks in the KOSPI200 index, stocks ranked within the top 50 of all common stocks in the KOSPI market can be selected as constituent stocks even before the regular revision date, applying the average market capitalization over 15 trading days after the listing date. Park Wonbae, a researcher at KB Securities, analyzed, "The cutoff for the average market capitalization ranking 50 for this criterion is estimated to be about 4.5 trillion KRW, which corresponds to 57,461 KRW in stock price terms. Based on the previous day's closing price, SK Biopharm's market capitalization at listing was 13.8615 trillion KRW, ranking 21st in the KOSPI market, and the average market capitalization over 10 trading days since listing was 15 trillion KRW, exceeding the cutoff by 3.3 times." Park added, "Unless there is an unexpected event, SK Biopharm will be included in the KOSPI200 index starting from September 11, the day after the simultaneous expiration of September options."

This content was produced with the assistance of AI translation services.